Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study

KK Ray, E Bruckert, B Van Hout… - European Heart …, 2020 - academic.oup.com
Background 2019 ESC/EAS dyslipidaemia guidelines recommend a 50% lowering in
untreated LDL-C and use of PCSK9 inhibitors (PCSK9i) for patients at very-high …
被引用次数：6 相关文章

Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study

KK Ray, E Bruckert, B Van Hout… - European Heart …, 2020 - academic.oup.com
Background 2019 ESC/EAS dyslipidaemia guidelines recommend a 50% lowering in
untreated LDL-C and use of PCSK9 inhibitors (PCSK9i) for patients at very-high …